Login / Signup

A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial).

Peter John HutchinsonEllie EdlmannJohn Gerrard HanrahanDiederik O BultersArdalan H ZolnourianPatrick James HoltonNigel SuttnerKevin AgyemangSimon ThomsonIan A AndersonYahia Al-TamimiDuncan HendersonPeter WhitfieldMonica GherlePaul M BrennanAnnabel AllisonEric Peter ThelinSilvia TarantinoBeatrice PantaleoKaren CaldwellCarol Davis-WilkieHarry MeeElizabeth A WarburtonGarry BartonAswin ChariHani J MarcusSarah PyneAndrew Thomas KingAntonio BelliPhyo Kyaw MyintIan B WilkinsonThomas SantariusCarole TurnerSimon J BondAngelos G Koliasnull null
Published in: Health technology assessment (Winchester, England) (2024)
; Vol. 28, No. 12. See the NIHR Funding and Awards website for further award information.
Keyphrases
  • double blind
  • placebo controlled
  • phase iii
  • phase ii
  • clinical trial
  • study protocol
  • low dose
  • high dose
  • health information
  • open label
  • randomized controlled trial
  • healthcare